Header Logo

Connection

Yoshiko Usami to Cell Line

This is a "connection" page, showing publications Yoshiko Usami has written about Cell Line.
Connection Strength

0.333
  1. Usami Y, Wu Y, G?ttlinger HG. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature. 2015 Oct 08; 526(7572):218-23.
    View in: PubMed
    Score: 0.091
  2. Usami Y, Popov S, Weiss ER, Vriesema-Magnuson C, Calistri A, G?ttlinger HG. Regulation of CHMP4/ESCRT-III function in human immunodeficiency virus type 1 budding by CC2D1A. J Virol. 2012 Apr; 86(7):3746-56.
    View in: PubMed
    Score: 0.070
  3. Usami Y, Popov S, Popova E, G?ttlinger HG. Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase. J Virol. 2008 May; 82(10):4898-907.
    View in: PubMed
    Score: 0.054
  4. Usami Y, Popov S, G?ttlinger HG. Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site. J Virol. 2007 Jun; 81(12):6614-22.
    View in: PubMed
    Score: 0.050
  5. Olety B, Usami Y, Wu Y, Peters P, G?ttlinger H. AP-2 Adaptor Complex-Dependent Enhancement of HIV-1 Replication by Nef in the Absence of the Nef/AP-2 Targets SERINC5 and CD4. mBio. 2023 02 28; 14(1):e0338222.
    View in: PubMed
    Score: 0.038
  6. Weissenhorn W, Miguet N, Aschman N, Renesto P, Usami Y, Gottlinger HG. Structural basis of tetherin function. Curr HIV Res. 2012 Jun; 10(4):298-306.
    View in: PubMed
    Score: 0.018
  7. Zamborlini A, Usami Y, Radoshitzky SR, Popova E, Palu G, G?ttlinger H. Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding. Proc Natl Acad Sci U S A. 2006 Dec 12; 103(50):19140-5.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.